Filing Details
- Accession Number:
- 0000950170-24-084182
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-17 14:51:21
- Reporting Period:
- 2024-07-15
- Accepted Time:
- 2024-07-17 14:51:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1783183 | Phathom Pharmaceuticals Inc. | PHAT | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1363812 | Molly Henderson | C/O Phathom Pharmaceuticals, Inc. 100 Campus Drive, Suite 102 Florham NJ 07932 | Cfo And Cbo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-07-15 | 4,325 | $11.72 | 99,447 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,911 | Indirect | By 401(k) |
Footnotes
- Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.
- Includes 1,009 shares acquired under the Phathom Pharmaceuticals, Inc. employee stock purchase plan in July 2024.